Luppi et al.
9.6, 15.2 Hz), 2.74-2.85 (m, 1 H), 4.50-4.60 (m, 2 H), 5.03 (d,
1 H, J ) 9.6 Hz), 5.16 (AB, 2 H, J ) 12.4 Hz), 5.37 (dd, 1 H,
J ) 3.2, 9.6 Hz), 6.71 (s, 1 H), 6.83 (d, 1 H, J ) 7.2 Hz), 7.30-
7.39 (m, 5 H); 13C NMR (CDCl3) δ 15.9, 17.7, 19.7, 21.3, 24.3,
25.7, 28.2, 30.2, 32.1, 48.4, 57.2, 57.9, 59.4, 67.0, 79.6, 128.0,
128.3, 128.5, 135.3, 155.8, 167.0, 172.7, 173.4, 174.3. Anal.
Calcd for C29H42N4O8: C, 60.61; H, 7.37; N, 9.75. Found: C,
60.50; H, 7.45; N, 9.81.
(s, 9 H), 1.50 (d, 3 H, J ) 6.3 Hz), 2.22-2.44 (m, 1 H), 4.48 (d,
1 H, J ) 3.6 Hz), 4.72 (dq, 1 H, J ) 3.6, 6.3 Hz), 5.38-5.48
(m, 1 H), 9.60-10.02 (bs, 1 H); 13C NMR (CD3OD) δ 14.3, 18.8,
20.2, 27.6, 31.1, 62.0, 65.8, 74.7, 79.5, 152.2, 154.2, 171.2, 172.9.
Anal. Calcd for C15H24N2O7: C, 52.32; H, 7.02; N, 8.13.
Found: C, 52.34; H, 6.99; N, 8.07.
Boc-L-Va l-D-Oxd -Gly-L-Ala -OBn (13). For the synthetic
procedure from 12, see the preparation of Boc-L-Ala-L-pGlu-
Boc-L-Va l-L-Oxd -OBn (7). Boc-L-Val-OPfp (2 mmol, 0.76
g) was added to a stirred solution of H-L-Oxd-OBn (6) (1.2
Gly-L-Ala-OBn (4a ) above: yield 62%; mp ) 67-71 °C; [R]D )
9
+2.3 (c ) 0.8, CH2Cl2); IR (CH2Cl2) ν 3435, 3399, 3332, 1786,
1
mmol, 0.29 g), DIEA (5 mmol, 0.87 mL), and DMAP (0.81
mmol, 99 mg) in dry DMF (2 mL) under nitrogen atmosphere
at 0 °C. The mixture was stirred at room temperature for 2 h,
ethyl acetate (10 mL) was added, and the mixture was washed
with 1 M aqueous HCl (2 × 7 mL) and with an aqueous
saturated solution of NaHCO3 (1 × 10 mL). The combined
organic layers were dried over sodium sulfate, and the solvent
was removed under reduced pressure. The residue was purified
by silica gel chromatography (cyclohexane/ethyl acetate 7:3 as
eluant) and obtained in 45% yield as a liquid: [R]D ) -21.2
1746, 1706, 1686 cm-1; H NMR (CDCl3) δ 1.04 (d, 3 H, J )
6.6 Hz), 1.07 (d, 3 H, J ) 6.8 Hz), 1.41 (s, 9 H), 1.45 (d, 3 H,
J ) 7.6 Hz), 1.55 (d, 3 H, J ) 6.2 Hz), 1.98-2.18 (m, 1 H),
3.83 (dd, 1 H, J ) 5.8, 16.8 Hz), 4.03 (dd, 1 H, J ) 6.2, 16.8
Hz), 4.50 (d, 1 H, J ) 4.4 Hz), 4.59 (dq, 1 H, J ) 7.4 Hz), 4.82
(dq, 1 H, J ) 4.4, 6.2 Hz), 5.12 (d, 1 H, J ) 5.6 Hz), 5.20 (s, 2
H), 5.33 (dd, 1 H, J ) 5.6 Hz), 6.79 (d, 1 H, J ) 7.4 Hz), 7.20-
7.40 (m, 5 H), 7.80 (bs, 1 H); 13C NMR (CDCl3) δ 17.7, 18.1,
19.2, 21.2, 28.3, 30.2, 43.4, 48.2, 57.4, 62.9, 67.0, 74.7, 80.8,
127.9, 128.3, 128.5, 135.3, 151.5, 167.7, 168.0, 172.1, 174.2.
Anal. Calcd for C27H38N4O9: C, 57.64; H, 6.81; N, 9.96.
Found: C, 57.59; H, 6.84; N, 10.01.
(c ) 1.3, CH2Cl2); IR (CH2Cl2) ν 3393, 1791, 1752, 1699 cm-1
;
1H NMR (CDCl3) δ 0.79 (d, 3 H, J ) 7.0 Hz), 1.06 (d, 3 H, J )
6.6 Hz), 1.48 (s, 9 H), 1.55 (d, 3 H, J ) 6.2 Hz), 2.05-2.20 (m,
1 H), 4.50-4.62 (m, 2 H), 5.07 (d, 1 H, J ) 9.2 Hz), 5.21 (s, 2
H), 5.42 (dd, 1 H, J ) 3.6, 9.2 Hz), 7.25-7.42 (m, 5 H); 13C
NMR (CDCl3) δ 15.7, 19.7, 21.1, 28.3, 30.5, 57.1, 61.7, 68.1,
73.5, 80.0, 128.4, 128.7, 128.8, 134.4, 151.2, 155.8, 167.5, 172.9.
Anal. Calcd for C22H30N2O7: C, 60.82; H, 6.96; N, 6.45.
Found: C, 60.71; H, 7.06; N, 6.52.
Boc-L-Va l-D-Oxd -Aib-L-Ala -OBn (14). For the synthetic
procedure from 8, see the preparation of Boc-L-Val-L-pGlu-Aib-
L-Ala-OBn (5) above: yield 53%; mp ) 64-69 °C; [R]D ) +7.4
(c ) 0.5, CH2Cl2); IR (CH2Cl2) ν 3419, 3352, 1788, 1734, 1688
1
cm-1; H NMR (CDCl3) δ 0.95 (d, 3 H, J ) 7.2 Hz), 1.06 (d, 3
H, J ) 6.4 Hz), 1.41 (d, 3 H, J ) 6.8 Hz), 1.42 (s, 9 H), 1.51 (d,
3 H, J ) 6.2 Hz), 1.52 (s, 3 H), 1.55 (s, 3 H), 2.04-2.17 (m, 1
H), 4.35 (d, 1 H, J ) 3.6 Hz), 4.59 (dq, 1 H, J ) 6.8 Hz), 4.81
(dq, 1 H, J ) 3.6, 6.2 Hz), 5.06 (d, 1 H, J ) 5.6 Hz), 5.15 (AB,
2 H, J ) 12.8 Hz), 5.26 (bs, 1 H), 6.61 (d, 1 H, J ) 6.8 Hz),
7.00 (s, 1 H), 7.22-7.37 (m, 5 H); 13C NMR (CDCl3) δ 17.4,
18.3, 19.8, 21.4, 25.2, 28.6, 30.3, 31.2, 48.6, 52.6, 57.8, 63.6,
65.7, 67.3, 74.9, 80.6, 91.2, 128.4, 128.6, 128.8, 135.8, 152.0,
156.2, 167.2, 173.0, 173.6, 174.0. Anal. Calcd for C29H42N4O9:
C, 58.97; H, 7.17; N, 9.49. Found: C, 58.89; H, 7.11; N, 9.54.
Boc-L-Va l-L-Oxd -OH (8). For the synthetic procedure from
7, see the preparation of Boc-L-Ala-L-pGlu-OH (3a ) above: yield
98%; mp ) 118-122 °C; [R]D ) -7.4 (c ) 1.3, CH2Cl2); IR (CH2-
Cl2) ν 3350, 1786, 1706 cm-1; 1H NMR (CDCl3) δ 0.85 (d, 3 H,
J ) 6.9 Hz), 1.09 (d, 3 H, J ) 6.6 Hz), 1.46 (s, 9 H), 1.62 (d, 3
H, J ) 6.3 Hz), 2.18-2.42 (m, 1 H), 4.56 (d, 1 H, J ) 5.4 Hz),
4.65-4.85 (m, 1 H), 5.27 (d, 1 H, J ) 9.3 Hz), 5.32-5.48 (m, 1
H), 9.60-10.02 (bs, 1 H); 13C NMR (CDCl3) δ 16.1, 19.9, 21.4,
28.5, 30.8, 57.6, 61.9, 74.1, 80.7, 151.8, 156.5, 170.5, 171.1.
Anal. Calcd for C15H24N2O7: C, 52.32; H, 7.02; N, 8.13.
Found: C, 52.40; H, 7.06; N, 8.18.
Boc-L-Va l-L-P r o-Gly-L-Ala -OBn (15). This compound was
obtained following the NMM, HOBt, and EDCI protocol from
commercially available amino acids: mp ) 69-71 °C; [R]D
)
Boc-L-Va l-L-Oxd -Gly-L-Ala -OBn (9). For the synthetic
procedure from 8, see the preparation of Boc-L-Ala-L-pGlu-Gly-
-23.6 (c ) 0.3, CH2Cl2); IR (CH2Cl2) ν 3423, 3328, 1750, 1716,
1690, 1624 cm-1; 1H NMR (CDCl3) δ 0.88 (d, 3 H, J ) 6.8 Hz),
0.95 (d, 3 H, J ) 6.8 Hz), 1.42 (d, 3 H, J ) 8.0 Hz), 1.43 (s, 9
H), 1.90-2.22 (m, 5 H), 3.58-3.64 (m, 1 H), 3.66 (dd, 1 H, J )
4.4, 17.2 Hz), 3.76-3.88 (m, 1 H), 4.22-4.32 (m, 1 H), 4.62
(dq, 1 H, J ) 6.8 Hz), 5.09 (d, 1 H, J ) 9.6 Hz), 5.17 (AB, 2 H,
J ) 12.0 Hz), 6.64 (bs, 1 H), 7.20-7.44 (m, 6 H); 13C NMR
(CDCl3) δ 17.6, 19.3, 25.3, 28.4, 31.3, 43.1, 47.8, 48.2, 57.1,
60.8, 67.0, 79.1, 128.1, 128.3, 128.6, 135.5, 155.8, 168.8, 171.9,
172.2, 172.8. Anal. Calcd for C27H40N4O7: C, 60.88; H, 7.57;
N, 10.52. Found: C, 60.97; H, 7.62; N, 10.47.
L-Ala-OBn (4a ) above: yield 50%; mp ) 59-63 °C; [R]D
)
+18.7 (c ) 0.8, CH2Cl2); IR (CH2Cl2) ν 3423, 3390, 1792, 1680
1
cm-1; H NMR (CDCl3) δ 0.82 (d, 3 H, J ) 7.2 Hz), 1.07 (d, 3
H, J ) 6.9 Hz), 1.43 (s, 9 H), 1.44 (d, 3 H, J ) 6.6 Hz), 1.53 (d,
3 H, J ) 6.6 Hz), 2.14-2.22 (m, 1 H), 3.83 (dd, 1 H, J ) 4.8,
16.8 Hz), 4.15 (dd, 1 H, J ) 6.9, 16.8 Hz), 4.45 (d, 1 H, J ) 6.0
Hz), 4.61 (dq, 1 H, J ) 7.5 Hz), 4.69 (dq, 1 H, J ) 6.0 Hz), 5.10
(d, 1 H, J ) 7.0 Hz), 5.19 (AB, 2 H, J ) 12.0 Hz), 5.40-5.43
(m, 1 H), 7.04 (d, 1 H, J ) 6.9 Hz), 7.30-7.42 (m, 5 H), 7.55
(bs, 1 H); 13C NMR (CDCl3) δ 16.4, 17.9, 19.9, 20.4, 28.6, 30.8,
43.3, 48.6, 57.7, 63.8, 67.5, 74.4, 80.1, 128.3, 128.8, 128.9, 135.5,
151.9, 168.1, 168.4, 173.0, 174.4. Anal. Calcd for C27H38N4O9:
C, 57.64; H, 6.81; N, 9.96. Found: C, 57.71; H, 6.88; N, 9.89.
Boc-L-Va l-L-P r o-Aib-L-Ala -OBn (16). This compound was
obtained following the NMM, HOBt, and EDCI protocol from
commercially available amino acids: mp ) 152-155 °C;
[R]D ) -50.4 (c ) 1.0, CH2Cl2); IR (CH2Cl2) ν 3425, 3364, 1739,
1
Boc-L-Va l-D-Oxd -OBn (11). For the synthetic procedure
from 10,9 see the preparation of Boc-L-Val-L-Oxd-OBn (7)
above: liquid; 56% yield; [R]D ) +3.7 (c ) 1.8, CH2Cl2); IR
1699 cm-1; H NMR (CDCl3) δ 0.89 (d, 3 H, J ) 6.4 Hz), 0.96
(d, 3 H, J ) 7.2 Hz), 1.38 (d, 3 H, J ) 7.2 Hz), 1.39 (s, 3 H),
1.43 (s, 9 H), 1.44 (s, 3 H), 1.90-2.28 (m, 5 H), 3.56-3.64 (m,
1 H), 3.74-3.82 (m, 1 H), 4.25 (dd, 1 H, J ) 6.8, 9.2 Hz), 4.35
(dd, 1 H, J ) 4.8, 7.2 Hz), 4.54 (dq, 1 H, J ) 6.8 Hz), 5.09 (d,
1 H, J ) 9.6 Hz), 5.13 (AB, 2 H, J ) 12.0 Hz), 6.78 (s, 1 H),
7.20-7.40 (m, 6 H); 13C NMR (CDCl3) δ 18.0, 18.2, 19.7, 24.8,
25.6, 26.9, 28.1, 28.7, 31.7, 48.1, 48.7, 61.2, 67.2, 80.0, 128.3,
128.4, 128.7, 154.6, 170.9, 172.5, 172.9. Anal. Calcd for
1
(CH2Cl2) ν 3383, 1799, 1760, 1706 cm-1; H NMR (CDCl3) δ
0.89 (d, 3 H, J ) 6.6 Hz), 1.12 (d, 3 H, J ) 6.9 Hz), 1.48 (s, 9
H), 1.54 (d, 3 H, J ) 6.3 Hz), 2.26-2.44 (m, 1 H), 4.48 (d, 1 H,
J ) 3.9 Hz), 4.61 (dq, 1 H, J ) 3.9 Hz), 5.10 (d, 1 H, J ) 9.1
Hz), 5.26 (s, 2 H), 5.46 (dd, 1 H, J ) 3.9, 9.1 Hz), 7.29-7.45
(m, 5 H); 13C NMR (CDCl3) δ 16.5, 19.5, 21.2, 28.2, 31.1, 58.7,
62.0, 68.0, 73.6, 80.5, 128.3, 128.7, 134.6, 155.5, 167.5, 168.6,
172.9. Anal. Calcd for C22H30N2O7: C, 60.82; H, 6.96; N, 6.45.
Found: C, 60.88; H, 7.03; N, 6.55.
C
29H44N4O7: C, 62.12; H, 7.91; N, 9.99. Found: C, 62.18; H,
7.83; N, 10.05.
Com p u ta tion a l Meth od s. The starting guess structures
used for the DFT optimization of the analogous of 9 and 13
(i.e., MeOCO-L-Val-L-Oxd-Gly-L-Ala-OMe I and MeOCO-L-Val-
D-Oxd-Gly-L-Ala-OMe II, respectively) have been preliminary
located via AM1 optimizations. A set of reasonable structures
has been initially constructed so as to match the geometrical
Boc-L-Va l-D-Oxd -OH (12). For the synthetic procedure
from 11, see the preparation of Boc-L-Ala-L-pGlu-OH (3a )
above: yield 97%; mp ) 139-143 °C; [R]D ) +23.8 (c ) 0.8,
1
MeOH); IR (CH2Cl2) ν 3350, 1786, 1706 cm-1; H NMR (CD3-
OD) δ 0.83 (d, 3 H, J ) 6.9 Hz), 1.00 (d, 3 H, J ) 6.9 Hz), 1.44
1992 J . Org. Chem., Vol. 68, No. 5, 2003